Vita Coco (NASDAQ: COCO) director gets 1,530 deferred RSUs grant
Rhea-AI Filing Summary
Vita Coco Company, Inc. director Kenneth Sadowsky reported a routine equity compensation grant. He received 1,530 shares of Common Stock as deferred restricted stock units (RSUs) that vest in full on the earlier of the day before the next Annual Stockholders Meeting after the grant date or the first anniversary of the grant date, as long as he remains in continuous service. These deferred RSUs will settle on June 3, 2031, with each unit delivering one share of common stock. After this grant, Sadowsky directly holds 584,196 shares of Common Stock. He also holds a fully vested, currently exercisable non-qualified stock option covering 27,300 shares of Common Stock at an exercise price of $10.178 per share, expiring on January 2, 2030.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 1,530 shares
Net Buy
2 txns
Insider
Sadowsky Kenneth
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,530 | $75.18 | $115K |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Common Stock — 584,196 shares (Direct);
Non-Qualified Stock Option (Right to Buy) — 27,300 shares (Direct)
Footnotes (2)
- F1. Represents deferred RSUs granted under the company's 2021 Incentive Award Plan which vest in full the earlier of (i) the day immediately preceding the Annual Stockholders Meeting after the grant date or (ii) the first anniversary of the grant date provided that the Reporting Person remains in continuous service on the applicable vesting date. The Reporting Persons deferred RSUs will settle on June 3, 2031. Each deferred RSU represents the right to receive one share of common stock of the Issuer.
- F2. The stock option is fully vested and currently exercisable.
Key Figures
Deferred RSU grant: 1,530 shares
Shares held after grant: 584,196 shares
Option exercise price: $10.178 per share
+3 more
6 metrics
Deferred RSU grant
1,530 shares
Deferred RSUs granted to director on June 3, 2026
Shares held after grant
584,196 shares
Common Stock directly owned following transaction
Option exercise price
$10.178 per share
Non-qualified stock option strike price
Option underlying shares
27,300 shares
Common Stock underlying non-qualified stock option
Option expiration date
January 2, 2030
Non-qualified stock option expiry
RSU settlement date
June 3, 2031
Date deferred RSUs settle into common shares
Key Terms
deferred RSUs, 2021 Incentive Award Plan, Non-Qualified Stock Option (Right to Buy), vest in full, +1 more
5 terms
deferred RSUs financial
"Represents deferred RSUs granted under the company's 2021 Incentive Award Plan which vest in full..."
2021 Incentive Award Plan financial
"Represents deferred RSUs granted under the company's 2021 Incentive Award Plan which vest in full..."
Non-Qualified Stock Option (Right to Buy) financial
"Non-Qualified Stock Option (Right to Buy) ... underlying security title Common Stock"
vest in full financial
"RSUs granted under the company's 2021 Incentive Award Plan which vest in full the earlier of..."
continuous service financial
"provided that the Reporting Person remains in continuous service on the applicable vesting date"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Vita Coco (COCO) director Kenneth Sadowsky report?
Kenneth Sadowsky reported receiving 1,530 deferred RSUs of Vita Coco common stock as equity compensation. These RSUs are part of a grant under the 2021 Incentive Award Plan and are not an open-market stock purchase or sale.
How and when do Kenneth Sadowsky’s new Vita Coco (COCO) RSUs vest?
The 1,530 deferred RSUs vest in full on the earlier of the day before the next Annual Stockholders Meeting after the grant date or the first anniversary of the grant date, provided Sadowsky remains in continuous service on the vesting date.
What stock options does Kenneth Sadowsky hold in Vita Coco (COCO)?
Sadowsky holds a fully vested, currently exercisable non-qualified stock option for 27,300 shares of Vita Coco common stock with an exercise price of $10.178 per share. The option is scheduled to expire on January 2, 2030.
Is the Vita Coco (COCO) Form 4 a sign of insider buying or a compensation grant?
The Form 4 reflects a compensation-related grant, not open-market insider buying. The 1,530 shares are deferred RSUs awarded under the company’s 2021 Incentive Award Plan, vesting over time and settling into stock in 2031.